Effect of Transcutaneous Electrical Acupoint Stimulation on Dyspareunia

Patients will be divided randomly into two groups equal in number:

Control group (Group A): It will include 19 women with dyspareunia. They will receive only topical medication (lidocaine ointment applied as required for symptoms and 30 minutes before sexual activity).

Study group (GroupB): It will include 19 women with dyspareunia. They will receive Acu-TENS (30 minutes per session, once per week for 10 weeks), and topical medication (lidocaine ointment applied as required for symptoms and 30 minutes before sexual activity). All females will be given a full explanation of the study protocol and a consent form will be signed by each female before participating in the study

• Inclusion Criteria:

• Women complain of secondary dyspareunia, diagnosed and referred by the gynecologist.
• Multiparous women.
• Their ages will range from 25-35 years.
• Their body BMI will be less than 35 kg/m².
• Their pain level on the VAS will be ≥ 4.
• All the women were negative for vaginal infections caused by viruses, bacteria or fungi.
• Exclusion Criteria:

• Pregnancy
• Malignancy.
• The presence of an intrauterine device, vaginal infection, or skin/mucous lesions.
• Diabetes mellitus.
• Dermatological abnormalities on the skin at acupuncture point.
• Severe uncontrolled cardiac patients or implanted cardiac rhythm devices.
• Dyspareunia with endometriosis.
• Fearing from electricity.